TY - JOUR AU - Freedman, M. S. PY - 2006 DA - 2006// TI - Disease-modifying drugs for multiple sclerosis: current and future aspects JO - Expert Opin Pharmacother VL - 7 UR - https://doi.org/10.1517/14656566.7.1.S1 DO - 10.1517/14656566.7.1.S1 ID - Freedman2006 ER - TY - JOUR AU - Jongen, P. J. AU - Sindic, C. AU - Carton, H. AU - Zwanikken, C. AU - Lemmens, W. AU - Borm, G. PY - 2010 DA - 2010// TI - Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a JO - J Neurol VL - 257 UR - https://doi.org/10.1007/s00415-009-5378-x DO - 10.1007/s00415-009-5378-x ID - Jongen2010 ER - TY - JOUR AU - Jongen, P. J. AU - Lehnick, D. AU - Sanders, E. AU - Seeldrayers, P. AU - Fredrikson, S. AU - Andersson, M. AU - Speck, J. PY - 2010 DA - 2010// TI - Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study JO - Health Qual Life Outcomes VL - 8 UR - https://doi.org/10.1186/1477-7525-8-133 DO - 10.1186/1477-7525-8-133 ID - Jongen2010 ER - TY - JOUR AU - Trojano, M. AU - Pellegrini, F. AU - Fuiani, A. AU - Paolicelli, D. AU - Zipoli, V. AU - Zimatore, G. B. AU - Di Monte, E. AU - Portaccio, E. AU - Lepore, V. AU - Livrea, P. AU - Amato, M. P. PY - 2007 DA - 2007// TI - New Natural History of Interferon-Treated Relapsing Multiple Sclerosis JO - Ann Neurol VL - 61 UR - https://doi.org/10.1002/ana.21102 DO - 10.1002/ana.21102 ID - Trojano2007 ER - TY - JOUR AU - Vermeire, E. AU - Hearnshaw, H. AU - Van Royen, P. AU - Denekens, J. PY - 2001 DA - 2001// TI - Patient adherence to treatment: three decades of research. A comprehensive review JO - J Clin Pharm Ther VL - 26 UR - https://doi.org/10.1046/j.1365-2710.2001.00363.x DO - 10.1046/j.1365-2710.2001.00363.x ID - Vermeire2001 ER - TY - BOOK PY - 2003 DA - 2003// TI - Evidence for Action PB - World Health Organization CY - Geneva ID - ref6 ER - TY - CHAP AU - Sacket, D. L. AU - Snow, J. C. ED - Haynes, R. B. ED - Sackett, D. L. ED - Taylor, D. W. PY - 1979 DA - 1979// TI - The magnitude of compliance and non-compliance BT - Compliance in Health Care PB - Johns Hopkins University Press CY - Baltimore ID - Sacket1979 ER - TY - JOUR AU - Osterberg, L. AU - Blaschke, T. PY - 2005 DA - 2005// TI - Adherence to Medication JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra050100 DO - 10.1056/NEJMra050100 ID - Osterberg2005 ER - TY - JOUR AU - Tremlett, H. L. AU - Van der Mei, I. AU - Pittas, F. AU - Blizzard, L. AU - Paley, G. AU - Dwyer, T. AU - Taylor, B. AU - Ponsonby, A. L. PY - 2008 DA - 2008// TI - Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses JO - Pharmacoepidemiol Drug Saf VL - 17 UR - https://doi.org/10.1002/pds.1593 DO - 10.1002/pds.1593 ID - Tremlett2008 ER - TY - BOOK AU - Caon, C. AU - Lisak, D. AU - Penmesta, R. AU - Hreha, S. AU - Xiufang, K. AU - Tselis, A. AU - Lisak, R. P. AU - Khan, O. PY - 2008 DA - 2008// TI - Compliance and complications after 5 years of continual therapy with interferon-beta or glatiramer acetate in relapsing-remitting multiple sclerosis ID - Caon2008 ER - TY - JOUR AU - Lafata, J. E. AU - Cerghet, M. AU - Dobie, E. AU - Schulz, L. AU - Tunceli, K. AU - Reuther, J. AU - Elias, S. PY - 2008 DA - 2008// TI - Measuring adherence and persistence to disease modifying agents among patients with relapsing remitting multiple sclerosis JO - J Am Pharm Assoc VL - 48 UR - https://doi.org/10.1331/JAPhA.2008.07116 DO - 10.1331/JAPhA.2008.07116 ID - Lafata2008 ER - TY - JOUR AU - Mohr, D. C. AU - Likosky, W. AU - Boudewyn, A. C. AU - Marietta, P. AU - Dwyer, P. AU - Van der Wende, J. AU - Goodkin, D. E. PY - 1998 DA - 1998// TI - Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a JO - Mult Scler VL - 4 ID - Mohr1998 ER - TY - JOUR AU - Tremlett, H. L. AU - Oger, J. PY - 2003 DA - 2003// TI - Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS JO - Neurology VL - 61 UR - https://doi.org/10.1212/01.WNL.0000078885.05053.7D DO - 10.1212/01.WNL.0000078885.05053.7D ID - Tremlett2003 ER - TY - JOUR AU - Rio, J. AU - Porcel, J. AU - Tellez, N. AU - Sanchez-Betancourt, A. AU - Tintore, M. AU - Arevalo, M. J. AU - Nos, C. AU - Montalban, X. PY - 2005 DA - 2005// TI - Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis JO - Mult Scler VL - 11 UR - https://doi.org/10.1191/1352458505ms1173oa DO - 10.1191/1352458505ms1173oa ID - Rio2005 ER - TY - JOUR AU - Fraser, C. AU - Hadjimicheal, O. AU - Vollmer, T. PY - 2001 DA - 2001// TI - Predictors of Adherence to Copaxone Therapy in Individuals with Relapsing Remitting Multiple Sclerosis JO - J Neurosci Nurs VL - 33 UR - https://doi.org/10.1097/01376517-200110000-00003 DO - 10.1097/01376517-200110000-00003 ID - Fraser2001 ER - TY - JOUR AU - Mohr, D. C. AU - Boudewyn, A. C. AU - Likosky, W. AU - Levine, E. AU - Goodkin, D. E. PY - 2001 DA - 2001// TI - Injectable Medication for the Treatment of Multiple Sclerosis: The Influence of Self-Efficacy Expectations and Injection Anxiety on Adherence and the Ability to Self-Inject JO - Ann Behav Med VL - 23 UR - https://doi.org/10.1207/S15324796ABM2302_7 DO - 10.1207/S15324796ABM2302_7 ID - Mohr2001 ER - TY - JOUR AU - Ross, A. P. PY - 2008 DA - 2008// TI - Tolerability, adherence and patient outcomes JO - Neurology VL - 71 UR - https://doi.org/10.1212/WNL.0b013e31818f3dcb DO - 10.1212/WNL.0b013e31818f3dcb ID - Ross2008 ER - TY - CHAP AU - Haynes, R. B. AU - Ackloo, E. AU - Sahota, N. AU - McDonald, H. P. AU - Yao, X. PY - 2008 DA - 2008// TI - Interventions for enhancing medication adherence (Review) BT - Cochrane Database of Systematic Reviews ID - Haynes2008 ER - TY - BOOK PY - 2000 DA - 2000// TI - Dutch Medical Research Involving Human Subjects Act (WMO). International Publication Series Health, Welfare and Sport nr.2 ID - ref19 ER - TY - JOUR AU - Rigby, S. A. AU - Domenech, C. AU - Thornton, E. W. AU - Tedman, S. AU - Young, C. A. PY - 2003 DA - 2003// TI - Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale JO - Mult Scler VL - 9 UR - https://doi.org/10.1191/1352458503ms870oa DO - 10.1191/1352458503ms870oa ID - Rigby2003 ER - TY - JOUR AU - Vickrey, B. G. AU - Hays, R. D. AU - Harooni, R. AU - Myers, L. W. AU - Ellison, G. W. PY - 1995 DA - 1995// TI - A health-related quality of life measure for multiple sclerosis JO - Qual Life Red VL - 4 UR - https://doi.org/10.1007/BF02260859 DO - 10.1007/BF02260859 ID - Vickrey1995 ER - TY - JOUR AU - Jongen, P. J. AU - Sanders, E. AU - Visser, L. AU - Zwanikken, C. AU - Peters, G. AU - van der Tol, M. AU - Koopmans, P. AU - van Noort, E. PY - 2009 DA - 2009// TI - Automated On-Line Monitoring of Health-Related Quality of Life and Fatigue in Relapsing Remitting Multiple Sclerosis Patients Treated with Glatiramer Acetate (Optivit Study) JO - Neuroepidemiology VL - 33 ID - Jongen2009 ER - TY - JOUR AU - Gehi, A. K. AU - Ali, S. AU - Na, B. AU - Whooly, M. A. PY - 2007 DA - 2007// TI - Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease JO - Arch Intern Med VL - 167 UR - https://doi.org/10.1001/archinte.167.16.1798 DO - 10.1001/archinte.167.16.1798 ID - Gehi2007 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/11/40/prepub UR - http://www.biomedcentral.com/1471-2377/11/40/prepub ID - ref24 ER -